Cellular islet autoimmunity associates with clinical outcome of islet cell transplantation.
about
Report from IPITA-TTS Opinion Leaders Meeting on the Future of β-Cell ReplacementHuman pancreatic islet transplantation: an update and description of the establishment of a pancreatic islet isolation laboratoryEnhancing clinical islet transplantation through tissue engineering strategies.Serum Cytokines as Biomarkers in Islet Cell Transplantation for Type 1 DiabetesEvolution of β-Cell Replacement Therapy in Diabetes Mellitus: Islet Cell TransplantationClinical relevance of immune monitoring in solid organ transplantation.Islet alone versus islet after kidney transplantation: metabolic outcomes and islet graft survival.Recurrence of autoimmunity following pancreas transplantation.Current status of islet cell replacement and regeneration therapy.Recurrence of type 1 diabetes after simultaneous pancreas-kidney transplantation, despite immunosuppression, is associated with autoantibodies and pathogenic autoreactive CD4 T-cells.Persistent circulating human insulin in sheep transplanted in utero with human mesenchymal stem cells.Simultaneous detection of circulating autoreactive CD8+ T-cells specific for different islet cell-associated epitopes using combinatorial MHC multimers.Mesenchymal stem-cell immunosuppressive capabilities: therapeutic implications in islet transplantationMesenchymal stem cells as feeder cells for pancreatic islet transplantsHigh-throughput sequencing of islet-infiltrating memory CD4+ T cells reveals a similar pattern of TCR Vβ usage in prediabetic and diabetic NOD miceEvidence that HLA class I and II associations with type 1 diabetes, autoantibodies to GAD and autoantibodies to IA-2, are distinct.Preexisting autoantibodies predict efficacy of oral insulin to cure autoimmune diabetes in combination with anti-CD3.Update on islet transplantation.Potent induction immunotherapy promotes long-term insulin independence after islet transplantation in type 1 diabetesCXCR1/2 inhibition enhances pancreatic islet survival after transplantation.Immunosuppression in islet transplantationAlloantibody and autoantibody monitoring predicts islet transplantation outcome in human type 1 diabetes.Immune antibody monitoring predicts outcome in islet transplantation.Genetically engineered human islets protected from CD8-mediated autoimmune destruction in vivo.Islet transplantation in type 1 diabetes: ongoing challenges, refined procedures, and long-term outcomeRisk Factors for Type 1 Diabetes Recurrence in Immunosuppressed Recipients of Simultaneous Pancreas-Kidney Transplants.Outcomes of Pancreatic Islet Allotransplantation Using the Edmonton Protocol at the University of Chicago.Differences in baseline lymphocyte counts and autoreactivity are associated with differences in outcome of islet cell transplantation in type 1 diabetic patients.Current advances and travails in islet transplantation.Oxygenation of the Intraportally Transplanted Pancreatic Islet.Autologous and Allogenous Antibodies in Lung and Islet Cell Transplantation.Immune monitoring of pancreatic islet graft: towards a better understanding, detection and treatment of harmful events.Viruses and cytotoxic T lymphocytes in type 1 diabetes.Immune and cell therapy in type 1 diabetes: too little too late?Alternative transplantation sites for pancreatic islet grafts.Noninvasive imaging techniques in islet transplantation.T cell autoreactivity in the transplant milieu.Autologous regulatory T cells for the treatment of type 1 diabetes.The role of reactive oxygen species and proinflammatory cytokines in type 1 diabetes pathogenesis.Progress in immune-based therapies for type 1 diabetes.
P2860
Q26769878-6FAA35E1-4446-428F-85FE-9B1B074CF0ACQ27002000-1BCFC2C0-BE1F-4D82-BD2F-CF4CB707EDB5Q27692123-B47ACEEB-B631-4E1D-A0B0-4ED1D8ADC67EQ28552483-ECCEEA7F-4119-4F9E-9410-FDC0DE9D2898Q30430239-F7747091-454D-4693-9F49-15D37EA5EDF9Q33509142-FDC4D5FE-977B-4C9C-A2EB-6CF2AE3F23B4Q33588415-2E4021C6-8EEC-41E7-97DE-304424397A99Q33599426-651E7349-6F3D-4448-80A1-5A1499FB4193Q33738705-7446609C-89F6-43EF-85F7-BC74F835BF22Q33750748-8759AFEB-7E95-41D2-BB58-0391C98C06EEQ33787406-B475DAE5-E664-4AD0-B6C1-E715C71BF277Q33930268-574BEFFE-1967-47BD-B328-02F618EE2DD2Q34097940-004F84FC-BAA4-4ACC-AFF7-36A21B72F815Q34340690-BAE070C4-C74C-469B-AAE3-EF2EEC4CF305Q35022826-F783905B-32F4-4101-939A-7CEAF5EFEFD2Q35227148-2AB98943-ADB5-4DF3-97B7-6DC1DBB477AFQ35976614-8AD6A763-8603-4F87-B414-414EAFAFA367Q36065843-7F6CF510-52B7-4254-9A43-D432B8553D39Q36077883-DFDDA357-175B-47F5-87A2-FA9BF1F47EFCQ36290283-9C273581-2CC1-4298-9E5F-680F60B5460DQ36570514-15497FF4-49A4-40A0-B400-E1412A93995BQ36796037-5C48696F-C877-4967-B510-97D63392FD79Q36796105-CBB79499-025F-4B0A-AB35-C431534739ECQ37073103-507CEF98-1433-4FB7-A48C-69A81D78B91EQ37088225-F3ED3A12-2C93-4580-9E16-3802CCEC12ACQ37316533-900BB377-C744-45FD-8BC0-28CC5CEF153EQ37346582-32A9569A-0DE7-4023-8E56-323C78A61A89Q37360397-2B8C840E-56BA-4258-BC2B-4F31C74BFA88Q37360411-D46FBED1-0A2B-46C8-99DD-42C418EDD146Q37410835-C5DA60FB-FE49-46B5-AE1B-2981D7FC3759Q37528715-AFCC5FAE-268C-4D7C-840C-884B897E80A2Q37809052-D7D66480-9B6D-409C-A952-783B08FD8B9BQ37823420-1B59EBA3-9C4C-4218-B417-CA348730B8F1Q37853194-D9CFDFC2-9115-46C4-927E-BDD3A3AE9306Q37905693-5D808441-D63E-476B-88DA-2E2E83301A96Q37907894-DC0A2F97-5507-43AE-8EE9-EA0C94CE371CQ38014104-E6060FE9-D8CC-4D88-A49D-6159E9E5FFD5Q38030480-5D6DB4BC-5F57-48CF-BFA2-F7742F5FD9E6Q38074472-CD9B3CFD-BE83-41A2-ADB3-76560F66E7CCQ38097920-AB12A1A5-2C3F-4A9C-B9F5-35BD81E4C98C
P2860
Cellular islet autoimmunity associates with clinical outcome of islet cell transplantation.
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Cellular islet autoimmunity as ...... of islet cell transplantation.
@ast
Cellular islet autoimmunity as ...... of islet cell transplantation.
@en
type
label
Cellular islet autoimmunity as ...... of islet cell transplantation.
@ast
Cellular islet autoimmunity as ...... of islet cell transplantation.
@en
prefLabel
Cellular islet autoimmunity as ...... of islet cell transplantation.
@ast
Cellular islet autoimmunity as ...... of islet cell transplantation.
@en
P2093
P2860
P50
P1433
P1476
Cellular islet autoimmunity as ...... of islet cell transplantation.
@en
P2093
Bart Keymeulen
Bart O Roep
Daniel G Pipeleers
Dave L Roelen
Frans H J Claas
Frans K Gorus
Gabriëlle G M Pinkse
Gaby Duinkerken
Koen Verbeeck
Minke F J Versteeg-van der Voort Maarschalk
P2860
P356
10.1371/JOURNAL.PONE.0002435
P407
P577
2008-06-18T00:00:00Z